Stocks-ARWR-Arrowhead Pharmaceuticals Inc

ARWR Arrowhead Pharmaceuticals Inc

33.20 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 30/9/2023: Arrowhead Pharmaceuticals Inc's revenues decreased by 1.03% and amounted to 240.74M. Net income decreased by 18.57% to -209.28M. Net assets decreased by 31.36% to 287.16M and EPS decreased from -1.67 to -1.92.
ARWR's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
94.81%
Net Profit Margin
-63.07%
Operating Margin
-85.16%
Return On Investment
-18.22%